Remdesivir: a review in COVID-19
HA Blair - Drugs, 2023 - Springer
Remdesivir (Veklury®), a nucleotide analogue prodrug with broad-spectrum antiviral activity,
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State
A Libra, N Ciancio, G Sambataro, E Sciacca… - Viruses, 2023 - mdpi.com
Remdesivir is one of the most attractive options for patients with hypoxemic respiratory
failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate …
failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate …
Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay
J Figueredo, LF Lopez, BF Leguizamon… - BMC Infectious …, 2024 - Springer
Background The health crisis due to Covid-19 led to the search for therapeutics that could
improve the evolution of the disease. Remdesivir, an antiviral that interferes with viral …
improve the evolution of the disease. Remdesivir, an antiviral that interferes with viral …
[引用][C] Multi-state modeling of hospitalized patient data for prediction, etiology, and burden analyses-from hospital-acquired infections to pandemic settings
D Hazard - 2024 - Dissertation, Universität Freiburg …